BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

BioCardia (NASDAQ:BCDA) will report 2025 financial results and provide a corporate update on a conference call on March 24, 2026 at 4:30 PM EDT.

Rhea-AI Summary

BioCardia (NASDAQ:BCDA) will report 2025 financial results and provide a corporate update on a conference call on March 24, 2026 at 4:30 PM EDT. The event includes management remarks and a Q&A, with live webcast access and replay availability through June 24, 2026.

Registered participants receive dial-in details; domestic and international phone numbers and replay instructions are provided for listeners.

Market Context

This announcement schedules BioCardia’s full-year 2025 financial results and corporate update for Ma...

Analysis

This announcement schedules BioCardia’s full-year 2025 financial results and corporate update for March 24, 2026 at 4:30 PM EDT, continuing its established pattern of quarterly and annual calls. Investors may focus on how these results intersect with recent FDA pre-submission progress for the Helix catheter and Phase III CardiAMP HF data. Key items to watch include cash trends, development priorities, and any guidance or timeline commentary tied to recent regulatory milestones.

Key Figures

Results period: Year ended December 31, 2025 Call date: March 24, 2026 Call time: 4:30 PM EDT +5 more

Results period

Year ended December 31, 2025

Financial results to be discussed on the call

Call date

March 24, 2026

Corporate update and 2025 results conference call

Call time

4:30 PM EDT

Scheduled start time for prepared remarks and Q&A

U.S. dial-in

1-833-316-0559

Phone access for U.S. participants not pre-registered

International dial-in

1-412-317-5730

Phone access for international participants

Replay end date

June 24, 2026

Approximate end of webcast replay availability

Replay dial-in (US/Canada)

1-855-669-9658

Toll-free replay access for domestic/Canada listeners

Replay access code

7756290

Code required for telephonic replay

Previous Conferences,earnings Reports

5 past events · Latest: Nov 05

Same Type 5 events

1. Nov 05

   Q3 2025 call notice

   24h Move

   -3.0%

   Scheduled Q3 2025 corporate update and financial results conference call.

2. Aug 06

   Q2 2025 call notice

   24h Move

   -5.5%

   Announced Q2 2025 earnings conference call and corporate update timing.

3. May 09

   Q1 2025 call notice

   24h Move

   -0.3%

   Scheduled Q1 2025 corporate update and financial results call.

4. Mar 21

   2024 results & call

   24h Move

   +7.7%

   Outlined 2024 financial results release and accompanying conference call.

5. Nov 06

   Q3 2024 call notice

   24h Move

   -1.2%

   Announced Q3 2024 corporate update and financial results conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the year ended December 31, 2025 by conference call on Tuesday, March 24, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session.

Participants can register for the conference by navigating to https://dpregister.com/sreg/10207584/1039b7a7360.

Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730. All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to join the BioCardia call. The conference call will also be available through a live webcast, which can be accessed through the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=5Vq7aAhd

A webcast replay of the call will be available approximately one hour after the end of the call through approximately June 24, 2026 at the following link: https://services.choruscall.com/ccforms/replay.html. A telephonic replay of the call will also be available and may be accessed by calling 1-855-669-9658 (toll free domestic/Canada), 1-412-317-0088 (international toll) by using access code 7756290.

About BioCardia®
BioCardia, Inc., headquartered in Sunnyvale, California, is a developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms. BioCardia also acts as a biotherapeutic delivery partner supporting therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information visit www.biocardia.com.

MEDIA CONTACT:
Miranda Peto, Investor Relations
mpeto@biocardia.com
(650) 226-0120

INVESTOR CONTACT:
David McClung, Chief Financial Officer
investors@biocardia.com
(650) 226-0120

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioCardia (BCDA) reporting its 2025 financial results and corporate update?

BioCardia will report results on March 24, 2026 at 4:30 PM EDT. According to the company, the announcement covers the year ended December 31, 2025 and includes management remarks followed by a Q&A session for investors.

How can investors join the BioCardia (BCDA) March 24, 2026 conference call?

Investors can register online to receive a dial-in number or call 1-833-316-0559 (U.S.) or 1-412-317-5730 (international). According to the company, callers should dial in about 10 minutes early and ask to join the BioCardia call.

Will BioCardia (BCDA) provide a live webcast and replay of the March 24, 2026 call?

Yes, a live webcast and replay will be available. According to the company, the webcast link is provided and a replay will be accessible approximately one hour after the call through June 24, 2026.

Is there a telephonic replay for the BioCardia (BCDA) March 24, 2026 conference call?

A telephonic replay will be available by phone with access code 7756290. According to the company, domestic toll-free and international numbers are provided for on-demand replay access.

What will the format be for BioCardia's (BCDA) March 24, 2026 corporate update?

The format will include formal management remarks followed by a question-and-answer session. According to the company, this structure lets management present results and then respond to investor and analyst questions live.